Medical Innovations & Services SRL
Medical Innovations & Services reported total assets of 110,034 € at the end of the 2026 financial year (annual accounts filed with the NBB on 09 Oct 2026).
The score of Medical Innovations & Services shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medical Innovations & Services's annual accounts
| 2026 | |
|---|---|
| Net result | 81,736 € |
| Equity | 85,070 € |
| Cash | 83,994 € |
| EBITDA | 107,097 € |
| Total assets | 110,034 € |
Filed annual accounts
- Year ended 30 Jun 2026filed on 09 Oct 2026
Medical Innovations & Services's financial analysis
- Solvency77.3%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medical Innovations & Services
Medical Innovations & Services's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1019.117.434
- VAT number
- BE1019117434
- Peppol
- Registered · 0208:1019117434 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jan 2025
- Registered office
- 2323 Hoogstraten
- Latest accounts
- 2026 · filed on 09 Oct 2026
- Activity
- Activities of holding companies (NACE 64210)
Medical Innovations & Services (SRL) has been based in Hoogstraten since 2025, active in: activities of holding companies. For 2026, it reports a net profit of 81,736 € and equity of 85,070 €; its revenue is not published. Its solvency stands at 77.3%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Medical Innovations & Services
Companies in the same business, of comparable size and area, outside its group.
- EBF Consulting Activities of holding companies Geel · balance sheet €2.07m
- Compad Management Activities of holding companies Destelbergen · balance sheet €1.68m
- Hefracon Activities of holding companies Moorslede · balance sheet 504,076 €
- BeliDender Activities of agents involved in the wholesale of timber and building materials Halle · balance sheet 12,263 €
- Van ZON & Aerts Holding Activities of holding companies Baarle-Hertog · balance sheet 607,318 €
- Rosim Activities of holding companies Kruisem · balance sheet 143,007 €
- Berunosa Activities of holding companies Middelkerke · balance sheet €1.52m
- Empros Development Activities of holding companies Ghent · balance sheet 825,782 €
Frequently asked questions about Medical Innovations & Services
What is the revenue of Medical Innovations & Services?
Medical Innovations & Services files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Medical Innovations & Services?
In Belgium, the VAT number is the company number prefixed with BE: BE1019117434 for Medical Innovations & Services, if the company is VAT-registered. Its company number (CBE) is 1019.117.434.
Where is the registered office of Medical Innovations & Services?
According to the CBE register, the registered office of Medical Innovations & Services is in 2323 Hoogstraten.
What is the equity of Medical Innovations & Services?
At the close of the 2026 financial year, the equity of Medical Innovations & Services amounts to 85,070 €, a solvency of 77.3% of total assets.
Who manages Medical Innovations & Services?
The register lists 1 active mandates at Medical Innovations & Services. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medical Innovations & Services
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →